These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 35112216)

  • 1. Direct quantification of optic nerve blood flow by 3D pseudo-continuous arterial spin labeling.
    Wang Q; Li L; Wang H; Chen W; Yang B; Qu X; Sun Y; Chai Z; Li T; Chen J; Meng G; Gong X; Wang N; Xian J
    J Neurosci Methods; 2024 Jan; 401():110007. PubMed ID: 37952831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How does deep learning/machine learning perform in comparison to radiologists in distinguishing glioblastomas (or grade IV astrocytomas) from primary CNS lymphomas?: a meta-analysis and systematic review.
    Guha A; Halder S; Shinde SH; Gawde J; Munnolli S; Talole S; Goda JS
    Clin Radiol; 2024 Jun; 79(6):460-472. PubMed ID: 38614870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guess What Is in My Brain.
    Joseph C
    J Adv Pract Oncol; 2024 Jan; 15(1):60-64. PubMed ID: 39119082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of arterial spin labeling imaging for predicting prognosis after a recurrence of high-grade glioma in patients under bevacizumab treatment.
    Kambe A; Kitao S; Ochiai R; Hosoya T; Fujii S; Kurosaki M
    J Neurooncol; 2024 Jan; 166(1):175-183. PubMed ID: 38165552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral Microstructural and Microvascular Changes in Non-Neuropsychiatric Systemic Lupus Erythematosus: A Study Using Diffusion Kurtosis Imaging and 3D Pseudo-Continuous Arterial Spin Labeling.
    Wang X; Huang L; Guo W; Tang L; Wu A; Wu P; Zhao X; Lin Q; Yu L
    J Inflamm Res; 2023; 16():5465-5475. PubMed ID: 38026250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perifocal Zone of Brain Gliomas: Application of Diffusion Kurtosis and Perfusion MRI Values for Tumor Invasion Border Determination.
    Zakharova NE; Batalov AI; Pogosbekian EL; Chekhonin IV; Goryaynov SA; Bykanov AE; Tyurina AN; Galstyan SA; Nikitin PV; Fadeeva LM; Usachev DY; Pronin IN
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D pseudo-continuous arterial spin labeling-MRI (3D PCASL-MRI) in the differential diagnosis between glioblastomas and primary central nervous system lymphomas.
    Batalov AI; Afandiev RM; Zakharova NE; Pogosbekyan EL; Shulgina AA; Kobyakov GL; Potapov AA; Pronin IN
    Neuroradiology; 2022 Aug; 64(8):1539-1545. PubMed ID: 35112216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of 3D-pCASL MRI in the Differential Diagnosis of Glioblastoma and Brain Metastases.
    Solozhentseva K; Batalov A; Zakharova N; Goryaynov S; Pogosbekyan E; Pronin I
    Front Oncol; 2022; 12():874924. PubMed ID: 35558515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical primary central nervous system lymphoma and glioblastoma: multiparametric differentiation based on non-enhancing volume, apparent diffusion coefficient, and arterial spin labeling.
    Yu X; Hong W; Ye M; Lai M; Shi C; Li L; Ye K; Xu J; Ai R; Shan C; Cai L; Luo L
    Eur Radiol; 2023 Aug; 33(8):5357-5367. PubMed ID: 37171492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of Primary Central Nervous System Lymphoma From Glioblastoma: Quantitative Analysis Using Arterial Spin Labeling and Diffusion Tensor Imaging.
    Abdel Razek AAK; El-Serougy L; Abdelsalam M; Gaballa G; Talaat M
    World Neurosurg; 2019 Mar; 123():e303-e309. PubMed ID: 30502475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Skull Base Lesions Using Pseudo-Continuous Arterial Spin Labeling.
    Geerts B; Leclercq D; Tezenas du Montcel S; Law-Ye B; Gerber S; Bernardeschi D; Galanaud D; Dormont D; Pyatigorskaya N
    Clin Neuroradiol; 2019 Mar; 29(1):75-86. PubMed ID: 28894884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of arterial spin labelling MRI for discriminating atypical high-grade glioma from primary central nervous system lymphoma.
    Di N; Cheng W; Chen H; Zhai F; Liu Y; Mu X; Chu Z; Lu N; Liu X; Wang B
    Clin Radiol; 2019 Feb; 74(2):165.e1-165.e9. PubMed ID: 30415766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating between Primary Central Nervous System Lymphoma and Glioblastoma: The Diagnostic Value of Combining
    Hatakeyama J; Ono T; Takahashi M; Oda M; Shimizu H
    Neurol Med Chir (Tokyo); 2021 Jun; 61(6):367-375. PubMed ID: 33967177
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.